InfuSystem 11/7/2024 Earnings Report

InfuSystem EPS Results

• Actual EPS: $0.08
• Consensus EPS: $0.08
• Beat/Miss: Met Expectations
• One Year Ago EPS: N/A

InfuSystem Revenue Results

• Actual Revenue: $35.32 million
• Expected Revenue: $35.50 million
• Beat/Miss: Missed by -$180.00 thousand
• YoY Revenue Growth: N/A

InfuSystem Announcement Details

• Date: 11/7/2024
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

InfuSystem (NYSE:INFU) Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions. By integrating connected infusion pumps with data analytics and telehealth platforms, the company enables healthcare providers to monitor therapy progress, optimize patient outcomes and improve staff efficiency. This end-to-end model supports a broad range of IV infusion therapies, including chemotherapy, pain management and antibiotic administration.

Headquartered in St. Petersburg, Florida, InfuSystem was founded in the late 1980s and has grown to serve healthcare facilities across the United States and select international markets. The company is governed by a board of directors and a management team with deep experience in medical device services and healthcare operations. InfuSystem continues to invest in technology and infrastructure to meet evolving regulatory requirements and the shifting landscape of outpatient care.